Study #2018-0552
A Phase III Trial of Pre-Operative Stereotactic Radiosurgery (SRS) versus Post-Operative SRS for Brain Metastases
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This phase III trial studies stereotactic radiosurgery (SRS) before surgery to see how well it works compared with SRS after surgery in treating patients with cancer that has spread to the brain (brain metastases). SRS is the delivery of focused, high-dose radiation given in a single session to the tumors, with a minimal dose given to uninvolved areas of the brain.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Malignant Neoplasm;Metastatic Malignant Neoplasm in the Brain
Study phase:
Phase III
Physician name:
Debra Yeboa
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.